Pancreatic Cancer Research

ResearcherCommonwealth Scientific and Industrial Research OrganisationNo recent work listed

Minoo J. Moghaddam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2078-006X; OpenAlex author ID A5114033952. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers

Papers 3

  1. Biomimetic Gemcitabine-Lipid Prodrug Nanoparticles for Pancreatic Cancer. Last author DOI 10.1002/cplu.202000253↗
  2. Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in … Last author DOI 10.1016/j.canlet.2020.08.045↗
  3. Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo. Co-author DOI 10.1371/journal.pone.0151475↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jerikho C. Bulanadi · 3 shared papers, 2016–2020 · strength 0.28
  2. Aiqun Xue · 3 shared papers, 2016–2020 · strength 0.28
  3. Ross C. Smith · 3 shared papers, 2016–2020 · strength 0.28
  4. Sohel M. Julovi · 3 shared papers, 2016–2020 · strength 0.28
  5. Anthony James Gill · 2 shared papers, 2016–2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.